Coumadin, Vitamin K, and a Plant-Based Diet
By Joel Fuhrman, M.D. www.drfuhrman.com
Dr. Fuhrman Addresses Patients’ Concerns About Using This Blood-Thinning Drug On A Healthful Diet.
I have been asked by multiple individuals to give a complete answer with guidelines for patients on Coumadin (Warfarin is the generic name) who have been told by their health professionals to avoid green vegetables because of the interaction between Coumadin and vitamin K.
This subject is of interest to me because I am a physician and author who advocates a green-vegetable- rich diet for both weight loss and disease reversal and longevity. As a proponent of a diet rich in leafy greens, broccoli, and other foods rich in vitamin K, my dietary recommendations often contradict the advice of dietitians, nurses, and doctors who advise their patients taking Coumadin to avoid vitamin K-containing foods.
The reason health professionals recommend that their patients on Coumadin avoid vitamin K-containing foods is because Coumadin produces its anticoagulation (blood thinning) effects by interfering with the activation of a vitamin K-dependent enzyme that is needed to build clotting factors.
When you ingest more vitamin K from green vegetables, you can decrease the effectiveness of Coumadin. A higher dose of the drug will then be required to maintain the recommended degree of blood thinning. The term “blood thinning” is a lay term that means a reduction in the natural ability of the body to form a blood clot.
The following definitions are important in order to understand this issue:
Coagulation: refers to the formation of blood clots formed by clotting factors and platelets, a normal body reaction when, for example, you cut yourself. Coumadin (Warfarin) is called an anticoagulant because it works against the formation of blood clots.
Thrombus/Thrombi: clots formed inside the blood vessels, typically to seal a defect in the vessel wall. These clots, when formed in the blood vessels that supply the heart with oxygen, cause heart attacks. Thrombus is singular; thrombi is plural.
Embolus/Emboli: a traveling clot, usually caused by a thrombus that breaks off and travels to a distal portion of the artery where it is narrower, occluding it, leading to a stroke, pulmonary infarction, or heart attack. A traveling thrombus is an embolus. Embolus is singular; emboli is plural.
In many cases, Coumadin is used as a preventive treatment to reduce the chance of forming emboli that could cause a stroke. Coumadin is most often prescribed for patients with atrial fibrillation, a common irregularity in the heart rate. When you have this irregular heartbeat, the turbulent flow of blood increases the likelihood of the formation of an embolus that can travel to the brain and cause a stroke. Coumadin therapy also is used by people who have experienced a serious blood clot.
Serious Side Effects
Since Coumadin is a drug given to prevent clots, the major side effect is bleeding. When you are taking Coumadin, you will not stop bleeding easily if you are cut. If you get in a car accident, you will more likely bleed to death. If you have a stomach ulcer or a broken blood vessel in your digestive tract while taking Coumadin, you can bleed to death.
The main problem with this medication is its very narrow therapeutic range—too much, and you can suffer from a major bleeding episode; too little, and it is ineffective at preventing embolic events. Patients have to be closely monitored with blood tests and their dose adjusted accordingly to make sure they are taking the correct amount.
According to current estimates, 70 percent of patients on Coumadin tend to stop taking the medicine because of frustration with blood tests, dosage changes, and side effects. While Coumadin monitoring is a medical necessity, many times the demands of heavy patient loads can make it very challenging for busy physicians to follow patients as closely as necessary.
Besides the risk of a major bleed, another serious but more infrequent complication of Coumadin therapy is drug-induced limb gangrene and skin necrosis.
Other adverse reactions that occur infrequently include white blood cell diseases, hair loss, allergic reactions, diarrhea, dizziness, hepatitis and abnormal liver function, skin rash, headache, nausea and/or vomiting, and itching.
Physicians treat patients with Coumadin primarily to decrease the occurrence of thrombo-embolism. They perceive that this risk has a greater clinical impact than the risk of Coumadin-induced bleeding. However, only recently has the extent of the risks of bleeding been thoroughly investigated.
A recent meta-analysis that pooled data from 33 separate studies examined the bleeding rates of patients who received at least three months of anticoagulation therapy. Major bleeding occurred at a rate of 7.22 per 100 patient-years, and fatal bleeding occurred at the rate of 1.3 per 100 patient-years.1 That means if 10 people were put on Coumadin therapy for ten years each, seven out of the ten would have suffered a bleeding event and one would have died from taking Coumadin.
Only For High-Risk Patients
Before 1990, Coumadin therapy for the prevention of stroke for those who had atrial fibrillation was limited to those who also had additional risk factors, such as rheumatic heart disease and prosthetic heart valves.
In recent years, however, hundreds of thousands of patients with atrial fibrillation, including those without significant accompanying risk factors, have been placed on Coumadin to decrease the risk of embolic stroke. Medical studies have shown that patients with atrial fibrillation, who also have other risk factors for strokes, did have a survival advantage and a reduced risk of strokes when Coumadin was prescribed. The results were considerably better than those in high-risk patients who only used aspirin, but not considerably better in patients who had only atrial fibrillation and no other serious risk factors.
Younger patients with atrial fibrillation and those without cardiac risk factors have not been demonstrated to have lived longer as a result of taking Coumadin. Aspirin does just as well in this low-risk group mainly because strokes are more infrequent.
The American College of Cardiology recommends aspirin, not Coumadin, for those patients with atrial fibrillation who have a relatively low risk for embolic stroke. That includes patients who do not have diabetes, advanced atherosclerosis, poorly controlled blood pressure, an enlarged heart, a recent embolic event, obesity, or who smoke. In other words, it is standard practice that treatment with Coumadin be guided by the risk of thromboembolic events and not be used for those patients at relatively low risk.
Eat More Healthfully and Stop Taking Coumadin.
The main problem with the studies that show that patients at risk of stroke benefit from anticoagulation with Coumadin is that they tested mostly high-risk patients on the typical disease-creating American diet, not low-risk patients on a vegetable- heavy, plant-based diet. As one’s diet changes to include more vegetation and less and less animal products and refined foods, one’s cholesterol drops, one’s blood pressure typically decreases, and one’s risk of a heart attack or embolic stroke plummets.
A high-nutrient, plant-based diet already has been demonstrated in medical studies to have a powerful effect at decreasing the risk of embolic stroke as well as heart attacks. In fact, in the Nurses Health Study a mere 5 servings per day of fruits and vegetables reduced risk of embolic stroke by 30 percent (and this is still a poor diet by my standards). 2 Another study looking at the consumption of greens, vegetables, and daily fruit consumption found a dramatic decrease in stroke incidence (approaching 50 percent) when they compared high and low fruit and vegetable consumption.3 My dietary recommendations, extremely low in salt and offering the equivalent of more than 10 servings per day of stroke-protecting produce, have been demonstrated to dramatically lower cholesterol and offer a much greater resistance to both strokes and heart attacks than Coumadin therapy. For people following my nutritional advice, the use of Coumadin becomes ill-advised. The use of this dietary intervention quickly drops people from a high-risk to a low risk status. In most cases, Coumadin is no longer needed.
Most people on Coumadin would be much safer if they ate an ideal diet with lots of vitamin K-containing greens; took an aspirin, EPA/DHA fatty acids, and LDL protect daily; and stopped taking the Coumadin. The risk of all causes of death would decrease precipitously. Eating right will not cause you to bleed to death. Instead, it can save your life.
Natural anticoagulants to consider instead of Coumadin are tomato juice, pomegranate juice, fish oil, vitamin E, horse chestnut seed extract, and ginkgo biloba.
Is Coumadin The Only Hope?
For those who absolutely must take Coumadin, because of a recent thrombotic event, the danger of not eating a healthful diet exceeds the risk of increasing the Coumadin dose slightly to accommodate the healthier diet. As long as the amount of greens you eat is consistent, your doctor can adjust your Coumadin dose to accommodate it.
For the patient who must stay on Coumadin, the diet must be consistent from day to day to avoid fluctuations in the effectiveness of the drug. To keep the vitamin K amount constant, it is sensible to eat one large raw salad a day and one serving of dark green vegetables such as asparagus and string beans, but leave out the dark green leafy vegetables, such as steamed kale, collards, and spinach. Adding some of those to a soup is okay, however. The goal is to keep your vitamin K level stable, so the amount of blood thinning does not swing into a danger zone. A dangerous level of blood thinning can occur if the dose of Coumadin is adjusted to a high vitamin K intake and then suddenly the patient does not eat many vitamin K-containing foods for a few days. In other words, the main goal is to eat the same amount of vitamin K-containing foods every day.
In summary, the evidence indicates that both Coumadin and aspirin are effective for prevention of emboli in patients with atrial fibrillation. Coumadin is more effective than aspirin in those very high-risk patients, but is associated with a higher rate of serious bleeding. The advice of the typical healthcare provider to severely limit vitamin K-containing foods does not consider the risk reduction that occurs from the dietary improvements. A diet high in processed foods and animal products, although low in vitamin K, will increase your risk of a heart attack and stroke. Instead, eat even more of those high-vitamin K foods and, if at all possible, get off the Coumadin.
1. Linkins LA, et al. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med 2003:139:893-901.
2. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999;282(13):1233-9.
3. Sauvaget C, Nagano J, Allen N, Kodama K. Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke 2003:34(10):2355-60.